U.S. FDA New Drug (NDA) and Biologic (BLA) Approvals, 2022 |
|||||
Filed* |
Q1 |
Q2 |
Q3 |
Q4 |
Cumulative |
NDAs |
21a |
22b |
21c |
31 |
96 |
BLAs |
7 |
5 |
10d |
15 |
37 |
Total |
27 |
28 |
34 |
46 |
133 |
Approved |
Q1 |
Q2 |
Q3 |
Q4 |
Cumulative |
Become a Plunkett Research Online subscriber to gain unlimited access to our massive amount of vital industry data and market research.
- ✔ 100,000 Industry Statistics
- ✔ 500 Industries Analyzed for Market Size, Profits and Forecasts
- ✔ 150,000 Industry Executives Profiled
- ✔ 25,000 Companies Profiled, Ranked and Analyzed
- ✔ 1,000 Vital Trends Analyzed, totaling 1,000,000 words